Fol. Biol. 2015, 61, 81-89

https://doi.org/10.14712/fb2015061020081

Curcumin-Mediated Reversal of p15 Gene Promoter Methylation: Implication in Anti-Neoplastic Action against Acute Lymphoid Leukaemia Cell Line

V. Sharma1, A. K. Jha1, A. Kumar1, A. Bhatnagar2, G. Narayan3, Jagdeep Kaur1

1Department of Biotechnology, Panjab University, Chandigarh, India
2Department of Biochemistry, Panjab University, Chandigarh, India
3Department of Molecular and Human Genetics, Banaras Hindu University, Varanasi, India

Received October 2014
Accepted March 2015

References

1. Aggarwal, B. B., Kumar, A., Bharti, A. C. (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23, 363-398.
2. Andreoli, F., Barbosa, A. J., Parenti, M. D., Del Rio, A. (2013) Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives. Curr. Pharm. Des. 19, 578-613. <https://doi.org/10.2174/138161213804581918>
3. Antunes, L. M., Araújo, M. C., Dias, F. L., Takahashi, C. S. (1999) Modulatory effects of curcumin on the chromosomal damage induced by doxorubicin in Chinese hamster ovary cells. Teratog. Carcinog. Mutagen. 19, 1-8. <https://doi.org/10.1002/(SICI)1520-6866(1999)19:1<1::AID-TCM1>3.0.CO;2-7>
4. Cameron, E. E., Baylin, S. B., Herman, J. G. (1999) p15INK4B CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing. Blood 94, 2445-2451. <https://doi.org/10.1182/blood.V94.7.2445.419k19_2445_2451>
5. Chen, S. S., Raval, A., Johnson A. J., Hertlein, E., Liu, T. H., Jin, V. X. (2009) Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 106, 13433-13438. <https://doi.org/10.1073/pnas.0906455106>
6. Chim, C. S., Wong, A. S., Kwong, Y. L. (2003) Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias. Ann. Hematol. 82, 738-742. <https://doi.org/10.1007/s00277-003-0744-8>
7. Christman, J. (2002) 5-Azacytidine and 5-aza-2’-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 21, 5483-5495. <https://doi.org/10.1038/sj.onc.1205699>
8. Gong, J., Traganos, F., Darzynkiewicz, Z. (1994) A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal. Biochem. 218, 314-319. <https://doi.org/10.1006/abio.1994.1184>
9. Gronbaek, K., Nedergaard, T., Andersen, M. K., thor Straten, P., Guldberg, P., Møller, P., Zeuthen, J., Ebbe Hansen, N., Hou-Jensen, K., Ralfkiaer, E. (1998) Concurrent disruption of cell cycle associated genes in mantle cell lymphoma: a genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRb. Leukemia 12, 1266-1271. <https://doi.org/10.1038/sj.leu.2401090>
10. Heckenkamp, J., Leszczynski, D., Schiereck, J., Kung, J., LaMuraglia, G. M. (1999) Different effects of photodynamic therapy and γ-irradiation on vascular smooth muscle cells and matrix: implications for inhibiting restenosis. Arterioscler. Thromb. Vasc. Biol. 19, 2154-2161. <https://doi.org/10.1161/01.ATV.19.9.2154>
11. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., Baylin, S. B. (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93, 9821-9826. <https://doi.org/10.1073/pnas.93.18.9821>
12. Herman, J. G., Civin, C. I., Issa, J. P., Collector, M. I., Sharkis, S. J., Baylin, S. B. (1997) Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of haematological malignancies. Cancer Res. 57, 837-841.
13. Heyer, G., Saba, S., Adamo, R., Rush, W., Soong, G., Cheung, A., Prince, A. (2002) Staphylococcus aureus agr and sara functions are required for invasive infection but not inflammatory responses in the lung. Infect. Immun. 70, 127-133. <https://doi.org/10.1128/IAI.70.1.127-133.2002>
14. Jha, A. K., Nikbakht, M., Parashar, G., Shrivastava, A., Capalash, N., Kaur J. (2010) Reversal of hypermethylation and reactivation of the RARβ2 gene by natural compounds in cervical cancer cell lines. Folia Biol. (Praha) 56, 195-200.
15. Krishan, A. (1975) Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell. Biol. 66, 188-193. <https://doi.org/10.1083/jcb.66.1.188>
16. Lee, W. J., Shim, J. Y., Zhu, B. T. (2005) Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol. Pharmacol. 68, 1018-1030. <https://doi.org/10.1124/mol.104.008367>
17. Loriot, A., De Plaen, E., Boon, T., De Smet, C. (2006) Transient down-regulation of DNMT1 methyltransferase leads to activation and stable hypomethylation of MAGE-A1 in melanoma cells. J. Biol. Chem. 281, 10118-10126. <https://doi.org/10.1074/jbc.M510469200>
18. Melki, J. R., Warnecke, P., Vincent, P. C., Clark, S. J. (1998) Increased DNA methyltransferase expression in leukaemia. Leukemia 12, 311-316. <https://doi.org/10.1038/sj.leu.2400932>
19. Minami, K., Chano, T., Kawakami, T. (2010) DNMT3L is a novel marker and is essential for the growth of human embryonal carcinoma. Clin. Cancer Res. 16, 2751-2759. <https://doi.org/10.1158/1078-0432.CCR-09-3338>
20. Mizuno, S., Chijiwa, T., Okamura, T., Akashi, K., Fukumaki, Y., Niho, Y. (2001) Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 97, 1172-1179. <https://doi.org/10.1182/blood.V97.5.1172>
21. Palle, J., Frost, B. M., Forestier, E., Gustafsson, G., Nygren, P., Hellebostad, M., Jonsson, O. G., Kanerva, J., Schmiegelow, K., Larsson, R., Lönnerholm, G., (2005). Cellular drug sensitivity in MLL-rearranged childhood acute leukaemia is correlated to partner genes and cell lineage. Br. J. Haematol. 129, 189-198. <https://doi.org/10.1111/j.1365-2141.2005.05433.x>
22. Reuter, S., Gupta, S. C., Park, B., Goel, A., Aggarwal, B. B. (2011) Epigenetic changes induced by curcumin and other natural compounds. Genes Nutr. 6, 93-108. <https://doi.org/10.1007/s12263-011-0222-1>
23. Sanchez, Y., Simo, G. P., Calvin, E., Blas, E. D., Aller, P. (2010) Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines. J. Pharmacol. Exp. Ther. 335, 114-123. <https://doi.org/10.1124/jpet.110.168344>
24. Simon, H. U., Haj-Yehia, A., Levi-Schaffer, F. (2000) Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5, 415-418. <https://doi.org/10.1023/A:1009616228304>
25. Stone, S., Dayananth, P., Jiang, P., Weaver-Feldhaus, J. M., Tavtigian, S. V., Cannon-Albright, L. (1995) Genomic structure, expression and mutational analysis of the P15 (MTS2) gene. Oncogene 11, 987-991.
26. Sun, C., Liu, X., Chen, Y., Liu, F (2005) Anticancer effect of curcumin on human B cell non-Hodgkin’s lymphoma. J. Huazhong Univ. Sci. Technolog. Med. Sci. 25, 404-407.
27. Wajed, S. A., Laird, P. W., De Meester, T. R. (2001) DNA methylation: an alternative pathway to cancer. Ann. Surg. 234, 10-20. <https://doi.org/10.1097/00000658-200107000-00003>
28. Wong, I. H., Ng, M. H., Lee, J. C., Lo, K. W., Chung, Y. F., Huang, D. P. (1998) Transcriptional silencing of the p16 gene in human myeloma-derived cell lines by hypermethylation. Br. J. Haematol. 103, 168-175.
29. Wong, I. H., Lo, Y. M., Yeo, W., Lau, W. Y., Johnson, P. J. (2000) Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients. Clin. Cancer Res. 6, 3516-3521.
30. Yu, J., Peng, Y., Wu, L. C., Xie, Z., Deng, Y., Hughes, T., He, S., Mo, X. K., Chiu, M., Wang, Q. E., He, X., Shujun Liu, S., Grever, M. R., Liu, Z. (2013) Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia. PLoS One 8, e55934. <https://doi.org/10.1371/journal.pone.0055934>
31. Zhang, S. J., Endo, S., Ichikawa, T., Washiyama, K., Kumanishi, T (1998) Frequent deletion and 5’CpG island methylation of the p16 gene in primary malignant lymphoma of the brain. Cancer Res. 58, 1231-1237.
32. Zhang, Y. J., Wu, H. C., Shen, J., Ahsan, H., Tsai, W. Y., Yang, H. I. (2007) Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA. Clin. Cancer Res. 13, 2378-2384. <https://doi.org/10.1158/1078-0432.CCR-06-1900>
33. Zhongfa, L, Zhiliang, X., William, J., Ryan, E. P., Shujun, L., Jianhua, Y., Pui-kai, L., Jiayuh, L., Jame, R. F., Marcucci, G. M., Chenglong, L., Chan, K. K. (2009) Curcumin is a potent DNA hypomethylation agent. Bioorg. Med. Chem. Lett. 19, 706-709.
34. Zwaan, C. M., Kaspers, G. J., Pieters, R., Ramakers-Van Woerden, N. L, den Boer, M. L., Wünsche, R., Rottier, M. M., Hählen, K., van Wering, E. R., Janka-Schaub, G. E., Creutzig, U., Veerman, A. J. (2000) Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia. Blood 96, 2879-2886.
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive